^
Association details:
| Biomarker: | KIT V559_E561del |
|---|---|
| Cancer: | Gastrointestinal Stromal Tumor |
| Drug: | imatinib (c-KIT inhibitor, Bcr-abl tyrosine kinase inhibitor, PDGFR inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Title:
High frequency of c-KIT genetic variants in exons 9, 11, 13 and 17 and PDGFRA in exon 18 in gastric GIST tumors.
Published date:
05/28/2020
Excerpt:
Activating mutations in exon c-KIT were detected in 10 ps, including one substitution p.V560E and 4 deletions – p.V559_E561del, p.M552_V555delMYEV, p.W557_V559 > F and p.W557_V559 > C. These mutations cause sensitivity to imatinib.
DOI:
10.1200/JCO.2020.38.15_suppl.e23525
